Top Markets
Coin of the day
Raphael Pharmaceutical Inc. Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc.

RAPH
Rangering i aksjer #28150
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Aksjekurs
$1.40
Sist synkronisert: 2026-08-18
Markedsverdi
$28.25M
Endring (1 dag)
0.00%
Endring (1 år)
536.36%
Land
IL
Handel Raphael Pharmaceutical Inc. (RAPH)

Kategori

Historikk for aksjesplitt for Raphael Pharmaceutical Inc. (RAPH)
Aksjen Raphael Pharmaceutical Inc. (symbol: RAPH) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 20, 2026.
Én RAPH-aksje kjøpt før Aug 20, 2026 tilsvarer i dag 0 RAPH-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter